Work

The PROTACtable genome

Year: 2021

Type: review

Source: Nature Reviews Drug Discovery

DOI: 10.1038/s41573-021-00245-x

Authors: Melanie Schneider, Chris J. Radoux, Andrew Hercules, David Ochoa, Ian Dunham, Lykourgos-Panagiotis Zalmas, Gerhard Hessler, Sven Ruf, Veerabahu Shanmugasundaram, Michael M. Hann, Pam J. Thomas, Markus A. Queisser, Andrew B. Benowitz, Kris Brown, Andrew R. Leach

Institutions: European Bioinformatics Institute, Open Targets, Wellcome Sanger Institute, Sanofi (Germany), Bristol-Myers Squibb (United States), GlaxoSmithKline (United Kingdom), Agenus (United States), GlaxoSmithKline (United States)

Language: English

Topic: Protein Degradation and Inhibitors

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3186493235

FWCI: 4.461

Cites: 88

Cited by: 264

Related to: 10